ERS International Congress, Paris 2018

Browse by day: Saturday, 15.09.2018 Sunday, 16.09.2018 Monday, 17.09.2018 Tuesday, 18.09.2018 Wednesday, 19.09.2018		View the presentations you missed during Congress! More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

COPD and extrapulmonary comorbidities

Thematic Poster
Chairs: L. Vanfleteren (Haelen, Netherlands), F. Luppi (Modena, Italy), T. Lapperre (København NV, Denmark), B. Abascal Bolado (Santander (Cantabria), Spain)

Download all media

A study of the comorbidity of COPD and type 2 diabetes mellitus T. Makarova (Moscow, Russian Federation), V. Kobylyansky (Moscow, Russian Federation), O. Pivovarova (Moscow, Russian Federation), A. Sotnikova (Moscow, Russian Federation)
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus P. Titorenkov (Sofia, Bulgaria), M. Encheva (Sofia, Bulgaria), A. Chervenivanova (Sofia, Bulgaria), P. Chipev (Sofia, Bulgaria), D. Marinova (Sofia, Bulgaria), K. Kostov (Sofia, Bulgaria)
The "sweet" side of the Overlap Syndrome G. Castellana (Bari, Italy), L. Marra (Bari, Italy), S. Dragonieri (Bari, Italy), V. Di Lecce (Bari, Italy), P. Carratù (Bari, Italy), O. Resta (Bari, Italy)
Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus> K. Chen (Taipei, Taiwan), L. Chien (Taipei, Taiwan), C. Tseng (Taipei, Taiwan), K. Lee (Taipei, Taiwan)
The effect of comorbidities on long-term survival in COPD S. Eroglu (Istanbul, Turkey), H. Yakar (Istanbul, Turkey), E. Yildiz (Istanbul, Turkey), M. Kavas (Istanbul, Turkey), D. Duman (Istanbul, Turkey), H. Günen (Istanbul, Turkey)
Comorbidities in COPD - Impact on mortality S. Xavier pires (Porto, Portugal), P. Almeida (Porto, Portugal), M. Cravo (Porto, Portugal), M. Costa (Porto, Portugal), T. Oliveira (Porto, Portugal), S. Vieira Silva (Porto, Portugal), P. Leuschner (Porto, Portugal)
Effect of comorbidities on severity and clinical parameters of COPD S. Park (Jeonju, Republic of Korea), S. Park (Jeonju, Republic of Korea), C. Rhee (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea)
Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes M. Shahat Badawy (LLuxoruxor, Egypt), A. Rashaad (LuxorQena, Egypt), R. Mohamed (LQenauxor, Egypt)
COPD: CT Thorax - friend or foe’: Clinical utility of CT in diagnosing co-morbidities. A. Vohra (London, United Kingdom), S. Raza (London , United Kingdom), P. Dalal (London, United Kingdom), S. Kaul (London , United Kingdom)
Effects of comorbidities on physical activity in chronic obstructive pulmonary disease M. Yoshida (Fukuoka, Japan), A. Moriwaki (Fukuoka, Japan), H. Osoreda (Fukuoka, Japan), T. Hiramoto (Fukuoka, Japan), T. Iwanaga (Fukuoka, Japan), H. Inoue (Kagoshima, Japan)
A MULTILATERAL APPROACH TO COPD COMORBIDITIES A. Corlateanu (Chisinau, Republic of Moldova), S. Covantev (Chisinau, Republic of Moldova), E. Scutaru (Chisinau, Republic of Moldova), D. Rusu (Chisinau, Republic of Moldova), O. Corlateanu (Chisinau, Republic of Moldova), V. Botnaru (Chisinau, Republic of Moldova)
Gastro-oesophageal reflux, reflux-associated respiratory symptoms and severity of Chronic Obstructive Pulmonary Disease in Sri Lankan patients. D. Amarasiri (Colombo, Sri Lanka), S. Chaturanta (Colombo, Sri Lanka), H. Hettige (Colombo, Sri Lanka), D. Hitige (Ragama, Sri Lanka), N. Gunasekera (Ragama, Sri Lanka), K. Wickramaratna (Ragama, Sri Lanka), M. Nizamdeen (Colombo, Sri Lanka), K. Gunasekera (Colombo, Sri Lanka), C. Ranasinha (Ragama, Sri Lanka)
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD V. Su (Taipei, Taiwan)
The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD D. Burrage (London, United Kingdom), S. Ruickbie (London, United Kingdom), M. Bajaj (London, United Kingdom), C. Spilling (London, United Kingdom), J. Dodd (Bristol, United Kingdom), T. Barrick (London, United Kingdom), P. Jones (London, United Kingdom), E. Baker (London, United Kingdom)
Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease D. Viglino (Grenoble, France), A. Plazanet (Grenoble, France), S. Bailly (Grenoble, France), M. Benmerad (Grenoble, France), I. Jullian-Desayes (Grenoble, France), R. Tamisier (Grenoble, France), V. Leroy (Grenoble, France), J. Zarski (Grenoble, France), M. Maignan (Grenoble, France), M. Joyeux-Faure (Grenoble, France), J. Pépin (Grenoble, France)
COPD: clinical, personality characteristics and psychological defences in development of disadaptive types of attitude to illness S. Ovcharenko (Moscow, Russian Federation), E. Nikitenko (Moscow, Russian Federation), S. Enikolopov (Moscow, Russian Federation), B. Volel (Moscow, Russian Federation), Y. Galetskayte (Moscow, Russian Federation)
Sex differences in COPD comorbidities F. de Blasio (Turin, Italy), D. Dassetto (Turin, Italy), I. Aredano (Turin, Italy), F. Coni (Turin, Italy), R. Ambrosanio (Turin, Italy), A. Rella (Turin, Italy), R. Di Tria (Turin, Italy), C. Bucca (Turin, Italy)
Clinical characteristics and related risk factors of depression in patients with early COPD Y. Jo (Seoul, Republic of Korea), M. Kang (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), S. Han (Seoul, Republic of Korea)
Severe mental illness in COPD patients: findings from the primary care 2015-17 COPD audit G. Garnavos (London, United Kingdom), V. McMillan (London, United Kingdom), J. Holzhauer-Barrie (London, United Kingdom), N. Baxter (London, United Kingdom), J. Quint (London, United Kingdom), P. Stone (London, United Kingdom), C. Roberts (London, United Kingdom)
Anxiety and depression on exacerbation COPD patients J. Gjerazi (Fier, Albania), I. Tashi (Lushnje, Albania), J. Daka (Fier, Albania), J. Bushati (Tirane, Albania), P. Kapisyzi (Tirane, Albania)